Trader consensus for an 80.5% implied probability against a new pandemic before 2028 stems primarily from the lack of any pathogen currently exhibiting sustained, efficient human-to-human transmission on a global scale, despite active surveillance. Ongoing regional threats, including the 2026 Bundibugyo Ebola outbreak in the Democratic Republic of the Congo with thousands of cases, remain limited by direct-contact requirements that hinder widespread spread, consistent with historical patterns. Avian influenza, mpox clades, and other zoonotic candidates show localized or animal-driven circulation without crossing into pandemic thresholds. Post-COVID enhancements in genomic surveillance, the WHO Pandemic Agreement, and international health regulations have improved early detection, shifting expert focus toward longer-term risks rather than near-term emergence. Uncertainties persist around novel "Disease X" spillovers or model divergences, but current epidemiological data support the market-implied odds.